Scientists need public support for cloned tissue therapies
This week's BioNews reports on news that the American biotech company which funded last year's stem cell breakthrough has bought the commercial arm of the Roslin Institute. With the new acquisition, the Geron Corporation will now be able to marry the nuclear transfer technology developed at Roslin with the American...